Cyclin D1 expression analysis in familial breast cancers may discriminate BRCAX from BRCA2-linked cases
Open Access
- 1 October 2008
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 21 (10), 1262-1270
- https://doi.org/10.1038/modpathol.2008.43
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX familiesLaboratory Investigation, 2007
- Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma familiesEuropean Journal Of Cancer, 2007
- Evaluation of models to predict BRCA germline mutationsBritish Journal of Cancer, 2006
- Histopathology of BRCA1- and BRCA2-associated breast cancerCritical Reviews in Oncology/Hematology, 2006
- Characterization of Familial Non-BRCA1/2Breast Tumors by Loss of Heterozygosity and ImmunophenotypingClinical Cancer Research, 2006
- Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal PhenotypeClinical Cancer Research, 2005
- Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markersBreast Cancer Research and Treatment, 2005
- Estrogen Receptor Status in BRCA1 - and BRCA2 -Related Breast CancerClinical Cancer Research, 2004
- Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast CancerJNCI Journal of the National Cancer Institute, 2003
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995